Inventor · disambiguated record
Waldemar Priebe
Also filed as: PRIEBE WALDEMAR · PRIEBE WALDEMAR A
41 granted patents·12 pending applications·401 citations·filing 1982–2023
98Inventor score
Files withUNIV TEXAS25PRIEBE WALDEMAR11UNIV OHIO STATE RES FOUND3HOUSTON PHARMACEUTICALS INC2MOLECULIN BIOTECH INC2
Top patents by PatentIndex Score
53 records- 0194US8143412B2Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)PRIEBE WALDEMAR·Filed 2009·Granted Mar 27, 2012·27 cites·9 claims
- 0292US11980634B2Method of reconstituting liposomal annamycinMOLECULIN BIOTECH INC·Filed 2023·Granted May 14, 2024·3 cites·18 claims
- 0391US11951118B2Preparation of preliposomal annamycin lyophilizateMOLECULIN BIOTECH INC·Filed 2023·Granted Apr 9, 2024·1 cites·29 claims
- 0490US12257261B2Preparation of preliposomal Annamycin lyophilizateUNIV TEXAS·Filed 2021·Granted Mar 25, 2025·1 cites·17 claims
- 0590US8252740B2Thermally-targeted delivery of medicaments including doxorubicinRAUCHER DRAZEN·Filed 2007·Granted Aug 28, 2012·15 cites·14 claims
- 0689US12257262B2Method of reconstituting liposomal annamycinUNIV TEXAS·Filed 2021·Granted Mar 25, 2025·1 cites·16 claims
- 0788US8299033B2Iodo-hexose compounds useful to treat cancerPRIEBE WALDEMAR·Filed 2009·Granted Oct 30, 2012·14 cites·7 claims
- 0886US8450337B2Methods of treating skin disorders with caffeic acid analogsPRIEBE WALDEMAR·Filed 2009·Granted May 28, 2013·3 cites·6 claims
- 0985US5874412ABis-anthracyclines with high activity against doxorubicin resistant tumorsFiled 1997·Granted Feb 23, 1999·97 cites·25 claims
- 1083US6673907B2Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibioticsHOUSTON PHARMACEUTICALS INC·Filed 2001·Granted Jan 6, 2004·17 cites·48 claims
- 1181US7745468B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2004·Granted Jun 29, 2010·12 cites·23 claims
- 1280US8927506B2Acetates of 2-deoxy monosaccharides with anticancer activityPRIEBE WALDEMAR·Filed 2009·Granted Jan 6, 2015·5 cites·8 claims
- 1380US4537882A4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing sameUNIV OHIO STATE·Filed 1984·Granted Aug 27, 1985·21 cites·12 claims
- 1476US11026960B2Esters of 2-deoxy-monosaccharides with anti proliferative activityUNIV TEXAS·Filed 2018·Granted Jun 8, 2021·1 cites·5 claims
- 1576US10201554B2Esters of 2-deoxy-monosacharides with anti proliferative activityUNIV TEXAS·Filed 2014·Granted Feb 12, 2019·2 cites·8 claims
- 1675US8779151B2Orally bioavailable caffeic acid related anticancer drugsPRIEBE WALDEMAR·Filed 2007·Granted Jul 15, 2014·2 cites·27 claims
- 1775US7557090B2Anthracycline antibiotics and methods of treating cancer using the sameHOUSTON PHARMACEUTICALS INC·Filed 2006·Granted Jul 7, 2009·3 cites·34 claims
- 1874US5902604ASubmicron liposome suspensions obtained from preliposome lyophilizatesUNIV TEXAS·Filed 1995·Granted May 11, 1999·29 cites·2 claims
- 1972US11925654B2Esters of 2-deoxy-monosaccharides with anti proliferative activityUNIV TEXAS·Filed 2021·Granted Mar 12, 2024·0 cites·32 claims
- 2072US9096499B2Compounds for treatment of cell proliferative diseasesUNIV TEXAS·Filed 2014·Granted Aug 4, 2015·1 cites·10 claims
- 2172US9000179B2Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)UNIV TEXAS·Filed 2013·Granted Apr 7, 2015·1 cites·6 claims
- 2272US4863739ALiposome compositions of anthracycline derivativesUNIV TEXAS·Filed 1987·Granted Sep 5, 1989·24 cites·22 claims
- 2371US8648102B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2012·Granted Feb 11, 2014·1 cites·12 claims
- 2471US8119827B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2010·Granted Feb 21, 2012·1 cites·16 claims
- 2570US8637675B2Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)PRIEBE WALDEMAR·Filed 2012·Granted Jan 28, 2014·1 cites·16 claims
- 2667US10703721B2Caffeic acid derivatives and uses thereofUNIV TEXAS·Filed 2018·Granted Jul 7, 2020·1 cites·21 claims
- 2766US5625043AAnthracyclines with unusually high activity against cells resistant to doxorubicin and its analogsPRIEBE WALDEMAR·Filed 1995·Granted Apr 29, 1997·21 cites·19 claims
- 2865US7365096B2Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)UNIV TEXAS·Filed 2003·Granted Apr 29, 2008·3 cites·40 claims
- 2965US7238366B1Submicron liposome suspensions obtained from preliposome lyophilizatesUNIV TEXAS·Filed 1998·Granted Jul 3, 2007·24 cites·78 claims
- 3065US4427664A2'Halo derivatives of daunomycin, desmethoxy daunomycin, adriamycin and carminomycinUS HEALTH·Filed 1982·Granted Jan 24, 1984·11 cites·12 claims
- 3164US7928062B2Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)UNIV TEXAS·Filed 2007·Granted Apr 19, 2011·0 cites·11 claims
- 3264US6680300B2Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agentsUNIV TEXAS·Filed 2002·Granted Jan 20, 2004·1 cites·19 claims
- 3363US5132290AEsters of 3'-deaminodoxorubicin and liposomal compositions thereofUNIV TEXAS·Filed 1989·Granted Jul 21, 1992·11 cites·3 claims
- 3461US4697005A1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibioticsUNIV OHIO STATE RES FOUND·Filed 1985·Granted Sep 29, 1987·14 cites·13 claims
- 3561US2008167277A1Methods of treating skin disorders with caffeic acid analogsCONRAD CHARLES·Filed 2007·Application pending·0 cites
- 3659US6437105B1Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agentsUNIV TEXAS·Filed 1999·Granted Aug 20, 2002·11 cites·15 claims
- 3759US2013244986A1Methods of treating skin disorders with caffeic acid analogsMOLECULIN LLC·Filed 2013·Application pending·0 cites
- 3857US2025009727A1Water-soluble salts of dna binding agentsUNIV TEXAS·Filed 2022·Application pending·0 cites
- 3956US2022347168A1Lung targeted anticancer therapies with liposomal annamycinUNIV TEXAS·Filed 2022·Application pending·0 cites
- 4054US2010130434A1Hexose Compounds to Treat CancerUNIV TEXAS·Filed 2007·Application pending·0 cites
- 4152US2023130134A1Method of treating viral infections with hexose type monosaccharides and analogs thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 4251US2015094343A1Orally bioavailable caffeic acid related anticancer drugsUNIV TEXAS·Filed 2014·Application pending·0 cites
- 4349US4562177A3'-Amino-2' halo-anthracycline antibioticsUNIV OHIO STATE RES FOUND·Filed 1983·Granted Dec 31, 1985·5 cites·19 claims
- 4445US5977327ASynthesis of annamycinUNIV TEXAS·Filed 1997·Granted Nov 2, 1999·6 cites·13 claims
- 4545US4870058A14-Acyloxy-2'-halo-anthracycline anti-cancer antibioticsUNIV OHIO STATE RES FOUND·Filed 1988·Granted Sep 26, 1989·5 cites·6 claims
- 4645US2010144802A1Small Molecule Inhibitors for Immune ModulationHEIMBERGER AMY B·Filed 2008·Application pending·0 cites
- 4744US10358439B2DNA binding agents with a minor groove binding tailUNIV TEXAS·Filed 2016·Granted Jul 23, 2019·0 cites·20 claims
- 4844US2022175744A1Combinations of transcription inhibitors and immune checkpoint inhibitors for treatment of diseaseUNIV TEXAS·Filed 2020·Application pending·0 cites
- 4940US2012276108A1Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseasesPRIEBE WALDEMAR·Filed 2012·Application pending·0 cites
- 5038US2011275577A1Methods of treating dermatologic, gynecologic, and genital disorders with caffeic acid analogsMOLECULIN LLC·Filed 2011·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Waldemar Priebe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →